Lupin Limited has informed the Exchange regarding a press release dated September 28, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension".
Lupin Limited Press Release Sep 28 2026
Earlier from Lupin
- Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
- Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
- Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
- Lupin Limited Press Release Aug 17 2026